AKT1 and cancer: Accumulating evidence suggests that anthocyanins have therapeutic effects against various cancers, inhibiting the growth of a variety of tumor cells by exerting cytotoxic effects, causing DNA damage-induced cell cycle arrest and suppressing PI3K/Akt signaling.